| 03/12 | CROSSJECT : Validation of the ZENEO® Midazolam clinical batch |  |
| 23/11 | CROSSJECT : American Epilepsy Society Annual Meeting | |
| 19/10 | CROSSJECT : INPI 2021 Awards | |
| 19/10 | CROSSJECT : team will be participating to the next CPhI Worldwide Conferences | |
| 05/10 | CROSSJECT : First-half 2021 results and business update | |
| 24/09 | CROSSJECT : H1 21: unsurprising (as usual) | |
| 23/09 | Crossject Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 202.. | |
| 18/06 | CROSSJECT : Another good piece of news for the group | |
| 17/06 | A licensing agreement for Zeneo Hydrocortisone in the US and Canada (Crossject) | |
| 16/06 | CROSSJECT : US & Canada licensing agreement with Eton Pharmaceuticals for Crossject's ZENE.. | |
| 16/06 | CROSSJECT : US & Canada licensing agreement with Eton Pharmaceuticals for Crossject's ZE.. | |
| 16/06 | Crossject and Eton Pharmaceuticals Signed an Agreement for Zeneo® Hydrocortisone in the.. | |
| 15/06 | ETON PHARMACEUTICALS : Pharma Secures US, Canadian Rights to Crossject's Zeneo Hydrocortis.. | |
| 31/05 | CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant .. | |
| 06/05 | CROSSJECT : May 10-14, 21 | |
| 08/04 | CROSSJECT : 2020 Annual results and business update | |
| 31/03 | CROSSJECT : FY20 unsuprising; waiting for more | |
| 30/03 | Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31,.. | |
| 30/03 | Un perfume de fin de trimestre |  |
| 30/03 | EN DIRECTO DESDE LOS MERCADOS : Alstom, ArcelorMittal, Vallourec, Quadient, Amazon, J&J, D.. | |
| 09/03 | CROSSJECT : benefits from The French National Recovery Plan, with a €1.5 million grant | |
| 2020 | CROSSJECT : by the Human Factors and Ergonomics Society (HF | |
| 2020 | CROSSJECT : by the Human Factors and Ergonomics Society (HFES) | |
| 2020 | CROSSJECT : Biotech showcase Partnering | |
| 2020 | CROSSJECT : Stanley Caplan User Centered Product Design Award | |
| 2020 | CROSSJECT : January 11-15, 2021 | |
| 2020 | CROSSJECT : successfully raises €12 million in funding | |
| 2020 | CROSSJECT : A double bond issue | |
| 2020 | Crossject Société Anonyme announced that it has received €5.24 million in funding from .. | |
| 2020 | CROSSJECT : Update on the group's business | |
| 2020 | CROSSJECT : First-half 2020 results and business update | |
| 2020 | Crossject Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 202.. | |
| 2020 | CROSSJECT : appoints Don Zinn as VP US Business | |
| 2020 | CROSSJECT : Result of votes at Combined General Meeting of 25 june 2020 | |
| 2020 | CROSSJECT : End of the conversion of convertible bonds in 2019 | |
| 2020 | Crossject Société Anonyme announced that it will receive €5.24 million in funding from .. | |
| 2020 | CROSSJECT : No major changes after the release of the FY19 report | |
| 2020 | CROSSJECT : Meaningless FY19 results and product update | |
| 2020 | CROSSJECT : 2019 annual results and business update | |
| 2020 | CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant .. | |
| 2020 | CROSSJECT : Information relative au nombre de droits de vote et d'actions composant le cap.. | |
| 2019 | CROSSJECT : Extra-financing to increase visibility | |
| 2019 | Crossject Société Anonyme announced that it has received €5.7 million in funding | |
| 2019 | CROSSJECT : A €2.6m non-dilutive issue | |
| 2019 | Crossject Société Anonyme announced that it has received €2.6 million in funding from I.. | |
| 2019 | CROSSJECT : Cooperation agreement with the US Department of Defense | |
| 2019 | Crossject Société Anonyme announced that it has received €1.1 million in funding from B.. | |
| 2018 | Crossject Announces Earnings Results for the First Half Ended June 30, 2018 | |
| 2018 | CROSSJECT : On its way to reaching the market | |
| 2018 | Crossject Société Anonyme announced that it has received €2.3 million in funding from G.. | |
| 2018 | Crossject Société Anonyme Reports Earnings Results for the Year Ended December 31, 2017 | |
| 2018 | Crossject Société Anonyme cancelled the transaction announced on May 4, 2016 | |
| 2018 | CROSSJECT : Financial calendar 2018 | |
| 2018 | Crossject Société Anonyme announced that it expects to receive €5.25 million in funding | |
| 2017 | CROSSJECT : Interim 2017 results and business update | |
| 2017 | CROSSJECT : Business update | |
| 2017 | CROSSJECT : receives authorization to conduct Zeneo® Midazolam bioequivalence study | |
| 2017 | CROSSJECT : boosts its US commercial development efforts | |
| 2017 | CROSSJECT : boosts its US commercial development efforts | |
| 2016 | CROSSJECT - AFPRIC STUDY : patients approve needle-free injection. | |
| 2016 | Crossject Société Anonyme announced a financing transaction | |
| 2015 | CROSSJECT : Partnership agreement for ZENEO® Methotrexate in China with Xi'an Xintong Phar.. | |
| 2015 | CROSSJECT : secures €6.7 million in funding for the development of three new drugs | |
| 2015 | CROSSJECT : CORRECTION: CROSSJECT enters into partnering agreement with Sayre Therapeutics.. | |
| 2015 | CROSSJECT : 2015 half-year results & progress update | |
| 2015 | CROSSJECT : enters into partnering agreement with Sayre Therapeutics to commercialize ZENE.. | |
| 2015 | CROSSJECT : Publication of the 3rd Letter to the shareholders | |
| 2015 | CROSSJECT : confirms the development plan for ZENEO® Sumatriptan | |
| 2014 | CROSSJECT : Appoints Henri de Parseval as Supply Chain Director | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
